The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Ardelyx; Cara Therapeutics; Dynavax Technologies
Consulting or Advisory Role - Incyte; Novartis; Seagen
Speakers' Bureau - Incyte; Novartis; Seagen
E3A06: Randomized phase III trial of lenalidomide versus observation alone in patients with asymptomatic high-risk smoldering multiple myeloma.
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Susanna J. Jacobus
No Relationships to Disclose
 
Matthias Weiss
No Relationships to Disclose
 
Shaji Kumar
Honoraria - Dr. Reddy's
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Adaptive Biotechnologies; Amgen (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
 
Robert Z. Orlowski
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite, a Gilead company; Sanofi; Takeda
Research Funding - Amgen; BioTheryX; Spectrum Pharmaceuticals
 
Jonathan L. Kaufman
Honoraria - Janssen
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Karyopharm Therapeutics; Pharmacyclics; Roche; Takeda; TG Therapeutics
Research Funding - Celgene (Inst); Merck (Inst); Novartis (Inst)
 
Abdulraheem Yacoub
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Timothy E. O'Brien
No Relationships to Disclose
 
Jeffrey Matous
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Pharmacyclics
Speakers' Bureau - Celgene
Research Funding - Celgene (Inst); Seagen (Inst)
 
Daniel M. Anderson
Research Funding - Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Robert Emmons
No Relationships to Disclose
 
Madhav V. Dhodapkar
Honoraria - Bristol-Myers Squibb; Sanofi
Consulting or Advisory Role - Amgen; Janssen Oncology; Kite, a Gilead company; lava therapeutics; Roche/Genentech
 
Lynne I. Wagner
Consulting or Advisory Role - Celgene; EveryFit; Janssen
 
S. Vincent Rajkumar
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date